ACAS LLC’s Pfizer PFE Stock Holding History

ACAS LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$330K	Sell	13,097 -1,890	-13%	-$44.1K	0.22%	71
2025 Q1	$359K	Hold	14,987	–	–	0.27%	59
2024 Q4	$396K	Hold	14,987	–	–	0.29%	62
2024 Q3	$434K	Hold	14,987	–	–	0.36%	50
2024 Q2	$458K	Hold	14,987	–	–	0.4%	50
2024 Q1	$416K	Sell	14,987 -707	-5%	-$19.6K	0.4%	49
2023 Q4	$452K	Sell	15,694 -960	-6%	-$29K	0.51%	41
2023 Q3	$552K	Sell	16,654 -190	-1%	-$6.72K	0.68%	37
2023 Q2	$618K	Sell	16,844 -160	-0.9%	-$6.23K	0.83%	32
2023 Q1	$694K	Buy	17,004 +2,146	+14%	+$92.7K	1%	29
2022 Q4	$761K	Buy	+14,858	New	+$712K	1.18%	23
2022 Q2	$750K	Sell	14,858 -25	-0.2%	-$1.27K	1.12%	24
2022 Q1	$770K	Sell	14,883 -4,000	-21%	-$208K	1.04%	26
2021 Q4	$1.09M	Buy	18,883 +3,950	+26%	+$196K	1.41%	21
2021 Q3	$642K	Sell	14,933 -621	-4%	-$27.5K	0.89%	30
2021 Q2	$609K	Sell	15,554 -3,815	-20%	-$148K	0.86%	32
2021 Q1	$576K	Buy	+19,369	New	+$688K	0.9%	32

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

ACAS LLC's PFE Position: Q2 2025 in Review

ACAS LLC reduced its Pfizer (PFE) stake by 13% in Q2 2025, selling an estimated $44.1K and leaving 13,097 shares worth $330K. The position accounts for 0.22% of the portfolio, ranked #71.

ACAS LLC first reported a position in PFE in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.09M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

ACAS LLC held 13,097 shares of Pfizer worth $330K as of Q2 2025.
ACAS LLC sold 1,890 Pfizer shares in Q2 2025, an estimated $44.1K.
Pfizer made up 0.22% of ACAS LLC's portfolio in Q2 2025, its #71 holding.
ACAS LLC first reported a position in Pfizer in Q1 2021 and has held it in 17 quarters since.
ACAS LLC's Pfizer position peaked at $1.09M in Q4 2021.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on ACAS LLC's 13F filing for Q2 2025, filed 14 Aug 2025.